NextCure, Inc. — Director's Dealing 2019

May 9, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2019-05-08

Reporting Person: Mayer Timothy (SVP, Corporate Development)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$.48	2026-09-01	Common Stock (43565)		Direct
Employee Stock Option (Right to Buy)	$1.21	2027-03-15	Common Stock (31118)		Direct
Employee Stock Option (Right to Buy)	$1.77	2028-08-27	Common Stock (24894)		Direct
Employee Stock Option (Right to Buy)	$7.63	2028-12-21	Common Stock (78418)		Direct

Footnotes

F1: One fourth of the option vested on September 1, 2017. The remainder vests in 36 monthly installments beginning on October 1, 2017.

F2: One fourth of the option vested on March 15, 2018. The remainder vests in 36 monthly installments beginning on April 15, 2018.

F3: One fourth of the option vested on March 15, 2019. The remainder vests in 36 monthly installments beginning on April 15, 2019.

F4: One fourth of the option vests on December 21, 2019. The remainder vests in 36 monthly installments beginning on January 21, 2019.